Regions
2022 preview: Healthcare
Healthcare’s high-cost, rapidly digitizing profile will persist regardless of how COVID-19 plays out in the coming years. China appears set for consolidation, including in biotech
2022 preview: India tech
As India’s technology sector balloons, investors are balancing confidence about fundamentals with expectations of pushback. Both will play out in 2022 to some extent
BGH makes $432m bid for Australia's Virtus Health
BGH Capital has submitted a take-private bid for Virtus Health, an Australia-based fertility care services provider, that values the business at approximately A$607.3 million ($432 million).
Hong Kong's Brinc raises $130m for blockchain programs
Hong Kong accelerator Brinc has raised $130 million for blockchain-related accelerator programs and a global expansion with support from Animoca Brands, a local segment leader backed by several VCs.
2022 preview: China sustainability
Green-tech investment, from electric vehicles to renewable energy, is already in the ascendency as China ponders a carbon-neutral future. Momentum is expected to grow in 2022
2022 preview: China fundraising
Investors held fire on commitments to China managers amid uncertainty over regulatory reforms. Industry participants hope the government will provide clarity, but the fear LPs won’t hurry back
2022 preview: Macro & buyout
Will the bullish investment environment persist through 2022? Most Asia-based private equity players expect to remain busy, although they acknowledge a lack of visibility around macro and geopolitical risk
2022 preview: SaaS
Software-as-a-service continues to benefit from a digitalization push across multiple markets. Investors are looking for differentiation in a market characterized by high valuations and intense competition
China supermarket chain T11 raises $100m
T11, a China-based, technology-enabled supermarket chain, has raised a $100 million Series B led by Alibaba Group. Other investors include Redview Capital and MSA Capital.
Japan's Global Brain launches two VC funds, expands global remit
Japan’s Global Brain has launched its eighth flagship VC fund, seeking JPY40 billion ($352 million) for a more international-facing mandate. It has also launched a follow-on fund targeting JPY10 billion.
Deal focus: LingoAce shakes up Chinese class
Singapore’s LingoAce is leveraging growing interest in learning the Chinese language with an entertainment-focused education platform. Sequoia Capital India is backing a global expansion
Q&A: Legend Capital's Richard Li
Richard Li, president of Legend Capital, on evolving US-China relations, the logic behind the recent wave of regulation, investing in line with government policy, and why LPs should get used to onshore exits
Deal focus: Longreach eyes long overdue EnTie exit
Mindful of how political maneuvering has undone previous sale processes of Taiwan’s EnTie Commercial Bank, The Longreach Group is on edge as regulators prepare to rule on a $1.2 billion tie-up with IBF Financial
2021 in review: Boom time
Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince
China's Avistone Pharmaceuticals raises $200m
Avistone Pharmaceuticals, a Beijing biotech company focused on precision oncology therapeutics has raised more than $200 million in a Series A funding round led by Vivo Capital.
Endeavor United to buy chemicals unit from Japan's Bridgestone
Endeavour United, a Japanese private equity firm established by the team behind turnaround investor Phoenix Capital, has agreed to buy Bridgestone Corporation’s chemical products solutions business for an undisclosed sum.
TPG, ADIA, Temasek join funding round for Vietnam's The CrownX
The CrownX, a Vietnam-based consumer brands and retail business, has raised $350 million in funding from investors including TPG, Abu Dhabi Investment Authority (ADIA), and Temasek Holdings.
India's Shiprocket gets $185m Series E
Indian logistics aggregator Shiprocket has raised $185 million in Series E funding led by Lightrock India, Temasek Holdings, and Zomato.
PEP sells Australia, New Zealand healthcare businesses
Pacific Equity Partners (PEP) has agreed two healthcare exits, with Australia-based medical devices distributor LifeHealthcare to be sold to Ebos Group and New Zealand corporate hospital platform Evolution Healthcare going to QIC and Sunsuper.
Biotech player CANbridge drops on debut after $87m HK IPO
CANbridge Pharmaceuticals, a Beijing-based drug developer that focuses on treatments for cancer and rare diseases, lost 27% in value on its Hong Kong trading debut following a HK$685.1 million ($87.8 million) IPO.
Blue Owl buys Asia-based placement agent
US alternative asset manager Blue Owl Capital has acquired Hong Kong placement agent Ascentium with a view to establishing a physical presence in the territory and pursuing a broader regional expansion.
OTPP joins KKR as investor in Australia's GreenCollar
Ontario Teachers’ Pension Plan (OTPP) has made an investment of undisclosed size in KKR-backed GreenCollar, an environmental services provider that helped establish Australia’s carbon credit market.
Diversity, inclusion agendas require patience - AVCJ Forum
Executing a diversity, equity, and inclusion (DEI) agenda in private equity requires intentionality, multiple areas of focus, and above all time, given the apprenticeship nature of the industry, the AVCJ Diversity & Inclusion Forum heard.
Australia fintech player Finder raises $21m
Finder, an Australian financial technology start-up with a diversified suite of retail investor services, has raised A$30 million ($21.5 million) from local VC firm Future Now Capital.